Some decisions in life deserve serious, thoughtful contemplation.Other times, you have to make a split-second decision and live with the consequences.Picking companies to pitch in hedge fund and private equity case studies falls somewhere in the middle.If you already have a few companies in mind, you need to decide on one quickly – but if you have no clue where […]
Others note continued opportunity in biotech.Robert Christian, who analyzes hedge funds as head of research at K2 Advisors and Franklin Templeton Solutions, said biotech stock-focused managers stand out as one of his favorite strategies among the few dozen he tracks.Christian’s optimism rests on what he called exciting new technologies that justify higher company valuations.”Biotech used to be about making life […]
Don’t Fret About Tobin’s QBloomberg has a piece this morning on another valuation indictor, this time it’s Tobin’s Q, showing that the stock market is dramatically overvalued.
If you sold every share of every company in the U.S. and used the money to buy up all the factories, machines and inventory, you’d have some cash left over. That, in a nutshell, […]
The way I do research has been the area that has changed and evolved the most since starting to invest. I used to put together detailed stock screeners on places like FINVIZ.com – Stock Screener. And look for companies that had good-looking ratios. That was about it.I looked for things like a high current ratio, high margins, growing revenues, high […]
Good to be back in the saddle after of a week of traveling in Silicon Valley, Napa and San Francisco. And I thought New York real estate prices were crazy.Whenever I am away, I like to ease back into the groove by reviewing some broad market and economic metrics. It isn’t that a lot changes in the day-to-day or even […]
Comedy movies and risky stock trading – linked?Attention stock-market followers – have you considered whether weekend comedy-movie attendance, and investment in risky stock-market assets on the following Monday might be linked? This question has been the subject of an in-depth investigation by Gabriele M. Lepori, (formerly) Assistant Professor of Finance at Copenhagen Business School, Denmark (now at Keele Management School, […]
It’s been a turbulent few days for the biotech sector with the NASDAQ Biotechnology Index declining 5.46% over the last five trading days. A major part of this decline was recorded on Monday as the sector reacted to negative pipeline updates from companies like Amgen (AMGN – Analyst Report) and Celladon (CLDN – Snapshot Report). Meanwhile, Biogen’s (BIIB – Analyst […]
Dyadic International Receives Two Additional Research Milestone Payments From BASFDyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company with patented and proprietary technologies used to develop and produce enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, today announced the receipt of $800,000 for achieving two additional research and development milestones in its funded […]
NEW YORK (AP) — The place where you can buy handmade dresses and crocheted dog costumes has a new hot seller: its own stock.Shares of arts and crafts retailer Etsy surged in opening trading on the Nasdaq Thursday. After pricing at $16 late Wednesday the stock opened at nearly double that, and hit a high of $35.73 in morning trading. […]
PrintSubscribeinvestingDid you miss the stock market rally? You’re not aloneBy Claes Bell, CFA • Bankrate.comIt’s often said that a rising tide lifts all boats, but a rising tide isn’t much help if you don’t have a boat. In the midst of a six-year market rally, more than half of Americans don’t own any stock investments at all, potentially missing out […]
